176 related articles for article (PubMed ID: 27460568)
1. Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Meisel SF; Rahman B; Side L; Fraser L; Gessler S; Lanceley A; Wardle J;
BMC Womens Health; 2016 Jul; 16():46. PubMed ID: 27460568
[TBL] [Abstract][Full Text] [Related]
2. Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK.
Meisel SF; Fraser LSM; Side L; Gessler S; Hann KEJ; Wardle J; Lanceley A;
BMJ Open; 2017 Dec; 7(12):e017675. PubMed ID: 29275340
[TBL] [Abstract][Full Text] [Related]
3. Population-based, risk-stratified genetic testing for ovarian cancer risk: a focus group study.
Meisel SF; Side L; Fraser L; Gessler S; Wardle J; Lanceley A
Public Health Genomics; 2013; 16(4):184-91. PubMed ID: 23838408
[TBL] [Abstract][Full Text] [Related]
4. Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Meisel SF; Pashayan N; Rahman B; Side L; Fraser L; Gessler S; Lanceley A; Wardle J
Breast; 2015 Jun; 24(3):237-41. PubMed ID: 25708717
[TBL] [Abstract][Full Text] [Related]
5. Attitudes towards a programme of risk assessment and stratified management for ovarian cancer: a focus group study of UK South Asians' perspectives.
Hann KEJ; Ali N; Gessler S; Fraser LSM; Side L; Waller J; Sanderson SC; Lanceley A;
BMJ Open; 2018 Jul; 8(7):e021782. PubMed ID: 30021754
[TBL] [Abstract][Full Text] [Related]
6. Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.
Hann KEJ; Fraser L; Side L; Gessler S; Waller J; Sanderson SC; Freeman M; Jacobs I; Lanceley A;
BMC Womens Health; 2017 Dec; 17(1):132. PubMed ID: 29246147
[TBL] [Abstract][Full Text] [Related]
7. The introduction of risk stratified screening into the NHS breast screening Programme: views from British-Pakistani women.
Woof VG; Ruane H; French DP; Ulph F; Qureshi N; Khan N; Evans DG; Donnelly LS
BMC Cancer; 2020 May; 20(1):452. PubMed ID: 32434564
[TBL] [Abstract][Full Text] [Related]
8. Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study.
Meisel SF; Freeman M; Waller J; Fraser L; Gessler S; Jacobs I; Kalsi J; Manchanda R; Rahman B; Side L; Wardle J; Lanceley A; Sanderson SC;
BMC Public Health; 2017 Nov; 17(1):882. PubMed ID: 29145813
[TBL] [Abstract][Full Text] [Related]
9. Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey.
Wegwarth O; Pashayan N; Widschwendter M; Rebitschek FG
BMC Public Health; 2019 May; 19(1):667. PubMed ID: 31146730
[TBL] [Abstract][Full Text] [Related]
10. Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.
Fallowfield L; Fleissig A; Barrett J; Menon U; Jacobs I; Kilkerr J; Farewell V;
Br J Cancer; 2010 Aug; 103(4):454-61. PubMed ID: 20648018
[TBL] [Abstract][Full Text] [Related]
11. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.
Sanderson SC; Wardle J; Jarvis MJ; Humphries SE
Prev Med; 2004 Sep; 39(3):458-64. PubMed ID: 15313084
[TBL] [Abstract][Full Text] [Related]
12. Women's awareness of ovarian cancer risks and symptoms.
Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
[TBL] [Abstract][Full Text] [Related]
13. Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study.
Vermeulen E; Henneman L; van El CG; Cornel MC
Eur J Public Health; 2014 Oct; 24(5):768-75. PubMed ID: 24068545
[TBL] [Abstract][Full Text] [Related]
14. A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
Eccleston A; Bentley A; Dyer M; Strydom A; Vereecken W; George A; Rahman N
Value Health; 2017 Apr; 20(4):567-576. PubMed ID: 28407998
[TBL] [Abstract][Full Text] [Related]
15. Attitudes about genetic testing for breast-ovarian cancer susceptibility.
Lerman C; Daly M; Masny A; Balshem A
J Clin Oncol; 1994 Apr; 12(4):843-50. PubMed ID: 8151327
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated with Acceptability, Consideration and Intention of Uptake of Direct-To-Consumer Genetic Testing: A Survey Study.
Stewart KFJ; Kokole D; Wesselius A; Schols AMWJ; Zeegers MP; de Vries H; van Osch LADM
Public Health Genomics; 2018; 21(1-2):45-52. PubMed ID: 30359983
[TBL] [Abstract][Full Text] [Related]
17. Population-based Genetic Testing for Precision Prevention.
Evans O; Manchanda R
Cancer Prev Res (Phila); 2020 Aug; 13(8):643-648. PubMed ID: 32409595
[TBL] [Abstract][Full Text] [Related]
18. Impact of Implementing B-RST
Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
[TBL] [Abstract][Full Text] [Related]
19. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
Hull LE; Haas JS; Simon SR
Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
[TBL] [Abstract][Full Text] [Related]
20. Public Preferences for Determining Eligibility for Screening in Risk-Stratified Cancer Screening Programs: A Discrete Choice Experiment.
Dennison RA; Taylor LC; Morris S; Boscott RA; Harrison H; Moorthie SA; Rossi SH; Stewart GD; Usher-Smith JA
Med Decis Making; 2023 Apr; 43(3):374-386. PubMed ID: 36786399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
